PG
Paul Grayson
OtherActiveVenture Partner at Versant Ventures
San Diego, United StatesFounded 2010
62
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Paul Grayson.
Investment Thesis & Strategy
Paul Grayson, as a Venture Partner at Versant Ventures, invests in various stages of biotech companies, seeking innovative solutions within the healthcare sector.
Portfolio Companies
Selected investments from their portfolio of 62 companies
T
Turnstone Biologics
Biotech · Series A, 0
C
Chinook Therapeutics
Biotech · Series A, 0
R
Respicardia
Healthcare · Series B, 0
N
Nouscom
Biotech · Series A, 0
Q
Quentis Therapeutics
Biotech · Series A, 0
P
Passage Bio
Biotech · Series A, 0
O
Oyster Point Pharmaceuticals
Biotech · Series A, 0
N
Nuvaira
Healthcare · Series B, 0
M
Metavention
Healthcare · Seed, 0
B
BlueRock Therapeutics
Biotech · Series A, 0
R
RayzeBio
Biotech · Series A, 0
M
Monte Rosa Therapeutics
Other · , 0
Frequently Asked Questions
Paul Grayson invests across multiple stages. Sign up to view detailed stage data.